LobbyingMEDICINES360 lobbying by quarter
MEDICINES360's latest lobbying report covers Q1 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $10K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
MEDICINES360
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $10K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $7,000 | 1 |
| Q1 2023 | $16.6K | 1 |
| Q2 2023 | $20.9K | 1 |
| Q3 2023 | $7,000 | 1 |
| Q4 2023 | $7,000 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $10K | 1 |
| Q4 2024 | $10K | 1 |
| Q1 2025 | $10K | 1 |
| Q2 2025 | $10K | 1 |
| Q3 2025 | $10K | 1 |
| Q4 2025 | $10K | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$118.4K · 14 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Defense, Dept of (DOD)7 reports
- Food & Drug Administration (FDA)7 reports
- Health & Human Services, Dept of (HHS)7 reports
- HOUSE OF REPRESENTATIVES7 reports
- Natl Institutes of Health (NIH)7 reports
- SENATE7 reports
Firms it paid
| Firm | ||
|---|---|---|
| G2G Consulting | $60K | 7 quarters |
| Waxman Strategies | $58.4K | 7 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHRISTOPHER WILLIAM COOPER | Chief Appropriations Counsel,Chief of Staff,Legislative Director,Senior Legislative Assistant,Legislative Assistant for David Joyce (2013-2023) & Legislative Assistant/ Correspondent,Staff Assistant,Legislative Intern for Steven LaTourette(2011-2013) | Q1 2026 |
| ELIZABETH POWELL | Legislative Director for Rep. Jim Langevin 2001-2002 and Legislative Director for Rep. Juanita Millender-McDonald 1997-2001 | Q1 2026 |
| KATHERINE M COLLINS | Deputy Director of Operations, The Executive Residence, Executive Office of the President (2011-2016) and Policy Associate, White House Cancer Moonshot Task Force, Office of the Vice President, Executive Office of the President (2016-2017) | Q1 2026 |
| JEREMY SHARP | LA,Rep Capps 2001-05 PSM, Sen HELP Comm 2007-10 LD, Sen Dodd 2010 DAS for Leg, HHS, 2011-13 Counselor, HHS, 2013-14 Dep Commissioner for Policy, FDA 2015-17 | Q2 2024 |
| VAISHNAVI NAGAMMAL JAWAHAR | Vice President/President of the Senate Kamala Harris, served as Domestic Policy Coordinator in 2023 | Q4 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 04/16for Q1 | G2G Consulting | Under $5,000 |
| 01/20for Q4 2025 | G2G Consulting | $10K |
| 25/10/14for Q3 2025 | G2G Consulting | $10K |
| 25/07/13for Q2 2025 | G2G Consulting | $10K |
| 25/04/21for Q1 2025 | G2G Consulting | $10K |
| 25/01/19for Q4 2024 | G2G Consulting | $10K |
| 24/10/15for Q3 2024 | G2G Consulting | $10K |
| 24/10/14for Q3 2024 | G2G Consulting | Under $5,000 |
| 24/07/15for Q2 2024 | Waxman Strategies | Under $5,000 |
| 24/07/15for Q2 2024 | Waxman Strategies | Under $5,000 |
| 24/04/16for Q1 2024 | Waxman Strategies | Under $5,000 |
| 24/01/18for Q4 2023 | Waxman Strategies | $7,000 |
| 23/11/06for Q3 2023 | Waxman Strategies | $7,000 |
| 23/07/17for Q2 2023 | Waxman Strategies | $20.9K |
| 23/04/20for Q1 2023 | Waxman Strategies | $16.6K |
| 23/01/17for Q4 2022 | Waxman Strategies | $7,000 |